BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

585 related articles for article (PubMed ID: 18771897)

  • 1. [Impact on morbidity and costs of methicillin-resistant Staphylococcus aureus nosocomial pneumonia in intensive care patients].
    Larue A; Loos-Ayav C; Jay N; Commun N; Rabaud C; Bollaert PE
    Presse Med; 2009 Jan; 38(1):25-33. PubMed ID: 18771897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morbidity and cost burden of methicillin-resistant Staphylococcus aureus in early onset ventilator-associated pneumonia.
    Shorr AF; Tabak YP; Gupta V; Johannes RS; Liu LZ; Kollef MH
    Crit Care; 2006; 10(3):R97. PubMed ID: 16808853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methicillin-resistant Staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapy.
    Shorr AF; Combes A; Kollef MH; Chastre J
    Crit Care Med; 2006 Mar; 34(3):700-6. PubMed ID: 16505656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costs of nosocomial pneumonia caused by meticillin-resistant Staphylococcus aureus.
    Ott E; Bange FC; Reichardt C; Graf K; Eckstein M; Schwab F; Chaberny IF
    J Hosp Infect; 2010 Dec; 76(4):300-3. PubMed ID: 20951471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are there differences in hospital cost between patients with nosocomial methicillin-resistant Staphylococcus aureus bloodstream infection and those with methicillin-susceptible S. aureus bloodstream infection?
    Ben-David D; Novikov I; Mermel LA
    Infect Control Hosp Epidemiol; 2009 May; 30(5):453-60. PubMed ID: 19344266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Methicillin-resistant Staphylococcus aureus nosocomial infections in ICU: risk factors, morbidity and cost].
    Lepelletier D; Ferréol S; Villers D; Richet H
    Pathol Biol (Paris); 2004 Oct; 52(8):474-9. PubMed ID: 15465267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health economic evaluation of patients treated for nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus: secondary analysis of a multicenter randomized clinical trial of vancomycin and linezolid.
    Niederman MS; Chastre J; Solem CT; Wan Y; Gao X; Myers DE; Haider S; Li JZ; Stephens JM
    Clin Ther; 2014 Sep; 36(9):1233-1243.e1. PubMed ID: 25066668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colonization with methicillin-resistant Staphylococcus aureus in ICU patients: morbidity, mortality, and glycopeptide use.
    Garrouste-Orgeas M; Timsit JF; Kallel H; Ben Ali A; Dumay MF; Paoli B; Misset B; Carlet J
    Infect Control Hosp Epidemiol; 2001 Nov; 22(11):687-92. PubMed ID: 11842988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased mortality associated with methicillin-resistant Staphylococcus aureus (MRSA) infection in the intensive care unit: results from the EPIC II study.
    Hanberger H; Walther S; Leone M; Barie PS; Rello J; Lipman J; Marshall JC; Anzueto A; Sakr Y; Pickkers P; Felleiter P; Engoren M; Vincent JL;
    Int J Antimicrob Agents; 2011 Oct; 38(4):331-5. PubMed ID: 21798720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for ICU-acquired methicillin-resistant Staphylococcus aureus infections.
    Oztoprak N; Cevik MA; Akinci E; Korkmaz M; Erbay A; Eren SS; Balaban N; Bodur H
    Am J Infect Control; 2006 Feb; 34(1):1-5. PubMed ID: 16443085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nosocomial MRSA infection in vascular surgery patients: impact on patient outcome.
    Cowie SE; Ma I; Lee SK; Smith RM; Hsiang YN
    Vasc Endovascular Surg; 2005; 39(4):327-34. PubMed ID: 16079941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes associated with bacteremia in the setting of methicillin-resistant Staphylococcus aureus pneumonia: a retrospective cohort study.
    Shorr AF; Zilberberg MD; Micek ST; Kollef MH
    Crit Care; 2015 Sep; 19(1):312. PubMed ID: 26335247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meticillin-resistant Staphylococcus aureus in the intensive care unit: its effect on outcome and risk factors for acquisition.
    McMaster J; Booth MG; Smith A; Hamilton K
    J Hosp Infect; 2015 Aug; 90(4):327-32. PubMed ID: 25997804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit.
    Chaix C; Durand-Zaleski I; Alberti C; Brun-Buisson C
    JAMA; 1999 Nov; 282(18):1745-51. PubMed ID: 10568647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The economic impact of methicillin-resistant Staphylococcus aureus in Canadian hospitals.
    Kim T; Oh PI; Simor AE
    Infect Control Hosp Epidemiol; 2001 Feb; 22(2):99-104. PubMed ID: 11232886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost of Gram-negative resistance.
    Evans HL; Lefrak SN; Lyman J; Smith RL; Chong TW; McElearney ST; Schulman AR; Hughes MG; Raymond DP; Pruett TL; Sawyer RG
    Crit Care Med; 2007 Jan; 35(1):89-95. PubMed ID: 17110877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of teicoplanin and linezolid therapies in patients with methicillin-resistant Staphylococcus aureus pneumonia acquired from respiratory intensive care unit].
    Taşbakan MS; Korkmaz Ekren P; Pullukçu H; Başarık B; Susur A; Aydemir S; Başoğlu OK; Bacakoğlu F
    Mikrobiyol Bul; 2010 Jul; 44(3):357-66. PubMed ID: 21063985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The attributable cost and length of hospital stay because of nosocomial pneumonia in intensive care units in 3 hospitals in Argentina: a prospective, matched analysis.
    Rosenthal VD; Guzman S; Migone O; Safdar N
    Am J Infect Control; 2005 Apr; 33(3):157-61. PubMed ID: 15798670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linezolid versus vancomycin for nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus in the elderly: A retrospective cohort analysis: Effectiveness of linezolid in the elderly.
    Takada H; Hifumi T; Nishimoto N; Kanemura T; Yoshioka H; Okada I; Kiriu N; Inoue J; Koido Y; Kato H
    Am J Emerg Med; 2017 Feb; 35(2):245-248. PubMed ID: 27832976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality risk factors with nosocomial Staphylococcus aureus infections in intensive care units: results from the German Nosocomial Infection Surveillance System (KISS).
    Gastmeier P; Sohr D; Geffers C; Behnke M; Daschner F; Rüden H
    Infection; 2005 Apr; 33(2):50-5. PubMed ID: 15827870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.